Lymphocytoplasmapheresis in multiple sclerosis: one-year results in 6 patients

Ital J Neurol Sci. 1986 Feb;7(1):119-23. doi: 10.1007/BF02230429.

Abstract

6 patients with definite MS underwent lymphocytoplasmapheresis for one year. Clinical data, evoked potential recordings and peripheral blood lymphocyte helper/suppressor ratio were assessed before and after the treatment and were compared with those of a control group of 10 multiple sclerosis patients. Lymphocytoplasmapheresis did not significantly modify clinical and laboratory findings compared with the control group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Evaluation Studies as Topic
  • Evoked Potentials, Auditory
  • Evoked Potentials, Somatosensory
  • Female
  • Humans
  • Leukapheresis*
  • Leukocyte Count
  • Male
  • Middle Aged
  • Multiple Sclerosis / blood
  • Multiple Sclerosis / physiopathology
  • Multiple Sclerosis / therapy*
  • T-Lymphocytes, Helper-Inducer / pathology
  • T-Lymphocytes, Regulatory / pathology
  • Time Factors